Study of Freefol-MCT PKPD in Healthy Volunteers
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adults males/Females aged over 20years
- Health screening examination within 60 days of the start (Interview, vital signs , 12-lead ECG, blood tests, urinalysis) .
- The applicant who agreed in writing by told an explanation enough about the characteristics of the study drug, the purpose of the test and the details.
Exclusion Criteria:
- Subjects with clinically significant disease or history such as Liver, kidney, gastrointestinal, respiratory, musculoskeletal, endocrine, nervous psychiatric, blood tumor system and cardiovascular. (In particular, bronchial asthma, severe hepatic, renal failure, severe blood disorders, severe myasthenia gravis, cardiac dysfunction, peptic ulcer, etc.)
- Who had acute disease or organ dysfunction within four weeks of the start of the test.
- Who had significant hematologic disorders or donate whole blood within two months of the start of the test.
- Significant neuropsychiatric or more.
- Continued drug abuse.
- Who has a history of drug and other hypersensitivity reactions.
- Positive at Type B / C hepatitis , syphilis tests (VDRL), if in AIDS antibody test
- Who took other clinical medicine within two months of the start of the test.
- Who smokes or drinks within two weeks after dosing.
- Who takes drugs regularly other than the mineral claim or vitamin. However, it depends on judgment of the researchers.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
A
Gender: 10 Males, 10 Females
|
|
|
B
Gender: 10 Males, 10 Females
|
|
|
C
Gender: 10 Males, 10 Females
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Non- compartment pharmacokinetic parameters
Time Frame: 1200 minutes
|
1200 minutes
|
|
Compartment pharmacokinetic parameters
Time Frame: 1200 minutes
|
1200 minutes
|
|
BIS
Time Frame: 1200 minutes
|
1200 minutes
|
|
SBP
Time Frame: 1200 minutes
|
1200 minutes
|
|
E0
Time Frame: 1200 minutes
|
1200 minutes
|
|
Emax
Time Frame: 1200 minutes
|
1200 minutes
|
|
Ce50
Time Frame: 1200 minutes
|
1200 minutes
|
|
ke0
Time Frame: 1200 minutes
|
1200 minutes
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Primary Completion (Anticipated)
Primary Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- Freefol_PKPD_2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.